Eli Lilly Collaboration

About Elektrofi

Elektrofi is a private, Boston-based biotech company founded in 2018, specializing in advanced drug delivery platforms. Its proprietary Hypercon™ microparticle technology enables the ultra-high concentration of biologic drugs, facilitating patient-friendly subcutaneous administration instead of lengthy IV infusions. The company has secured significant partnerships with major pharmaceutical firms like Janssen and Eli Lilly and recently closed a substantial $112.25 million Series C financing to scale manufacturing and advance clinical programs. Elektrofi operates as a platform technology company, driving a portfolio of partnered programs toward clinical development.

About Oblique Therapeutics

Oblique Therapeutics is a private, pre-revenue biotech leveraging its proprietary AbiProt® platform to generate novel antibody therapeutics against historically undruggable targets, primarily in pain and oncology. The company has validated its technology through strategic collaborations with major players like Eli Lilly and a leading animal health company. Led by an experienced team with a strong pharma background, Oblique aims to build a portfolio of assets while monetizing its platform through partnerships.

Therapeutic Areas